The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
Open accessAbstract
In the treatment of chronic hepatitis B (CHB), the ultimate goal is preventing hepatitis B virus (HBV)-associated liver disease, including hepatocellular carcinoma (HCC). Recently published studies show that in CHB patients treated with the currently recommended first-line nucleos(t)ide analogs (NAs) entecavir or tenofovir, annual HCC incidences range from 0.01% to 1.4% in non-cirrhotic patients, and from 0.9% to 5.4% in those with cirrhosis. In Asian studies including matched untreated controls, current NA therapy consistently resulted in a significantly lower HCC incidence in patients with cirrhosis, amounting to an overall HCC risk reduction of ∼30%; in non-cirrhotic patients, HCC risk reduction was overall ∼80%, but this was only observed in some studies. For patients of Caucasian origin, no appropriate comparative studies are available to date to evaluate the impact of NA treatment on HCC. Achievement of a virologic response under current NA therapy was associated with a lower HCC risk in Asian, but not Caucasian studies. Studies comparing entecavir or tenofovir with older NAs generally found no difference in HCC risk reduction between agents, except for one study which used no rescue therapy in patients developing lamivudine resistance. Overall, these data indicate that with the current, potent NAs, HCC risk can be reduced but not eliminated, probably due to risk factors that are not amenable to change by antiviral therapy, or events that may have taken place before treatment initiation. Validated pre- and on-therapy HCC risk calculators that inform the best practice for HCC surveillance and facilitate patient counseling would be of great practical value.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Fattovich, G., Bortolotti, F., & Donato, F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.011 · Cited by 1,348
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Marcellin, P., Heathcote, E. J., Buti, M., Gane, E., de Man, R. A., Krastev, Z., Germanidis, G., Lee, S. S., Flisiak, R., Kaita, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802878 · Cited by 1,181
Peck, M., Craxì, A., Fried, M., & Zeuzem, S. (2013) · Cited by 1,079
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Liaw, Y.-F., Kao, J.-H., Piratvisuth, T., Chan, H. L. Y., Chien, R.-N., Liu, C.-J., Gane, E., Locarnini, S., Lim, S.-G., Han, K.-H., et al. (2012) · Hepatology International · doi:10.1007/s12072-012-9365-4 · Cited by 1,038
Self-citationGenome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
Chang, T.-T., Liaw, Y.-F., Wu, S.-S., Schiff, E., Han, K.-H., Lai, C.-L., Safadi, R., Lee, S. S., Halota, W., Goodman, Z., et al. (2010) · Hepatology · doi:10.1002/hep.23785 · Cited by 972
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Arzumanyan, A., Reis, H. M. G. P. V., & Feitelson, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3449 · Cited by 800
Hosaka, T., Suzuki, F., Kobayashi, M., Seko, Y., Kawamura, Y., Sezaki, H., Akuta, N., Suzuki, Y., Saitoh, S., Arase, Y., et al. (2013) · Hepatology · doi:10.1002/hep.26180 · Cited by 710
Yang, H.-I., Yuen, M.-F., Chan, H. L.-Y., Han, K.-H., Chen, P.-J., Kim, D.-Y., Ahn, S.-H., Chen, C.-J., Wong, V. W.-S., & Seto, W.-K. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70077-8 · Cited by 669
Self-citationChang, T.-T., Lai, C.-L., Yoon, S. K., Lee, S. S., Coelho, H. S. M., Carrilho, F. J., Poordad, F., Halota, W., Horsmans, Y., Tsai, N., et al. (2010) · Hepatology · doi:10.1002/hep.23327 · Cited by 588
Yuen, M.-F., Tanaka, Y., Fong, D. Y.-T., Fung, J., Wong, D. K.-H., Yuen, J. C.-H., But, D. Y.-K., Chan, A. O.-O., Wong, B. C.-Y., Mizokami, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.023 · Cited by 584
Tseng, T., Liu, C., Yang, H., Su, T., Wang, C., Chen, C., Kuo, S. F., Liu, C., Chen, P., Chen, D., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.007 · Cited by 574
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Wong, V. W.-S., Chan, S. L., Mo, F., Chan, T.-C., Loong, H. H.-F., Wong, G. L.-H., Lui, Y. Y.-N., Chan, A. T.-C., Sung, J. J.-Y., Yeo, W., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2675 · Cited by 502
Self-citationWong, G. L.-H., Chan, H. L.-Y., Mak, C. W.-H., Lee, S. K.-Y., Ip, Z. M.-Y., Lam, A. T.-H., Iu, H. W.-H., Leung, J. M.-S., Lai, J. W.-Y., Lo, A. O.-S., et al. (2013) · Hepatology · doi:10.1002/hep.26301 · Cited by 488
Self-citationPapatheodoridis, G. V., Lampertico, P., Manolakopoulos, S., & Lok, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.035 · Cited by 459
Self-citationChen, H.-P., Shieh, J.-J., Chang, C.-C., Chen, T.-T., Lin, J.-T., Wu, M.-S., Lin, J.-H., & Wu, C.-Y. (2013) · Gut · doi:10.1136/gutjnl-2011-301708 · Cited by 392
Liu, S., Zhang, H., Gu, C., Yin, J., He, Y., Xie, J., & Cao, G. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp180 · Cited by 388
Jung, K. S., Kim, S. U., Ahn, S. H., Park, Y. N., Kim, D. Y., Park, J. Y., Chon, C. Y., Choi, E. H., & Han, K.-H. (2011) · Hepatology · doi:10.1002/hep.24121 · Cited by 388
Lee, M.-H., Yang, H.-I., Liu, J., Batrla-Utermann, R., Jen, C.-L., Iloeje, U. H., Lu, S.-N., You, S.-L., Wang, L.-Y., & Chen, C.-J. (2013) · Hepatology · doi:10.1002/hep.26385 · Cited by 322
Wu, C.-Y., Lin, J.-T., Ho, H. J., Su, C.-W., Lee, T.-Y., Wang, S.-Y., Wu, C., & Wu, J.-C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.048 · Cited by 319
Kew, M. C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06546.x · Cited by 279
Chen, G., Lin, W., Shen, F., Iloeje, U. H., London, W. T., & Evans, A. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00647.x · Cited by 275
Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Yang, J. D., Kim, W. R., Coelho, R., Mettler, T. A., Benson, J. T., Sanderson, S. O., Therneau, T. M., Kim, B., & Roberts, L. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.08.019 · Cited by 266
Natural history of hepatitis-related hepatocellular carcinoma
But, D.-Y.-K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1652 · Cited by 232
Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B
Wong, G. L.-H., Wong, V. W.-S., Choi, P. C.-L., Chan, A. W.-H., Chim, A. M.-L., Yiu, K. K.-L., Chan, H.-Y., Chan, F. K.-L., Sung, J. J.-Y., & Chan, H. L.-Y. (2009) · Gut · doi:10.1136/gut.2008.157735 · Cited by 229
Self-citationArends, P., Sonneveld, M. J., Zoutendijk, R., Carey, I., Brown, A., Fasano, M., Mutimer, D., Deterding, K., Reijnders, J. G. P., Oo, Y., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307023 · Cited by 210
Self-citationPrevention of hepatitis B virus–related hepatocellular carcinoma with antiviral therapy
Lai, C.-L., & Yuen, M.-F. (2013) · Hepatology · doi:10.1002/hep.25937 · Cited by 208
Papatheodoridis, G. V., Manolakopoulos, S., Touloumi, G., Vourli, G., Raptopoulou-Gigi, M., Vafiadis-Zoumbouli, I., Vasiliadis, T., Mimidis, K., Gogos, C., Ketikoglou, I., et al. (2011) · Gut · doi:10.1136/gut.2010.221846 · Cited by 186
Self-citationZoutendijk, R., Reijnders, J. G., Zoulim, F., Brown, A., Mutimer, D. J., Deterding, K., Hofmann, W. P., Petersen, J., Fasano, M., Buti, M., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302024 · Cited by 183
Self-citationAccuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment
Wong, G. L., Chan, H. L., Chan, H., Tse, P. C., Tse, Y., Mak, C. W., Lee, S. K., Ip, Z. M., Lam, A. T., Iu, H. W., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.002 · Cited by 172
Self-citationCho, J.-Y., Paik, Y.-H., Sohn, W., Cho, H. C., Gwak, G.-Y., Choi, M. S., Lee, J. H., Koh, K. C., Paik, S. W., & Yoo, B. C. (2014) · Gut · doi:10.1136/gutjnl-2013-306409 · Cited by 171
Lee, H. W., Yoo, E. J., Kim, B. K., Kim, S. U., Park, J. Y., Kim, D. Y., Ahn, S. H., & Han, K. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.157 · Cited by 162
Singal, A. K., Salameh, H. J., Kuo, Y. ‐., & Fontana, R. J. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12344 · Cited by 158
Lim, Y., Han, S., Heo, N., Shim, J. H., Lee, H. C., & Suh, D. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.033 · Cited by 151
Gordon, S. C., Lamerato, L. E., Rupp, L. B., Li, J., Holmberg, S. D., Moorman, A. C., Spradling, P. R., Teshale, E. H., Vijayadeva, V., Boscarino, J. A., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.062 · Cited by 143
Kumada, T., Toyoda, H., Tada, T., Kiriyama, S., Tanikawa, M., Hisanaga, Y., Kanamori, A., Niinomi, T., Yasuda, S., Andou, Y., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.025 · Cited by 142
Meta‐analysis: the association of hepatitis B virus genotypes and hepatocellular carcinoma
Wong, G. L., Chan, H. L., Yiu, K. K. L., Lai, J. W.-Y., Chan, V. K. ‐., Cheung, K. K. ‐., Wong, E. W. ‐., & Wong, V. W. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12207 · Cited by 117
Self-citationHsu, Y., Wu, C., Lane, H.-Y., Chang, C., Tai, C.-M., Tseng, C., Lo, G., Perng, D., Lin, J.-T., & Mo, L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku041 · Cited by 53
Kobashi, H., Miyake, Y., Ikeda, F., Yasunaka, T., Nishino, K., Moriya, A., Kubota, J., Nakamura, S., Takaki, A., Nouso, K., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00785.x · Cited by 45
Yang, S.-C., Lee, C.-M., Hu, T., Wang, J.-H., Lu, S.-N., Hung, C., Changchien, C. ‐., & Chen, C. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt147 · Cited by 42
Chronic Hepatitis B infection and liver cancer
Wong, C., & Goh, K. (2006) · Biomedical Imaging and Intervention Journal · doi:10.2349/biij.2.3.e7 · Cited by 25
Multivariate Regression Analysis
Graddy, E. A., & Wang, L. (2007) · Public administration and public policy · doi:10.1201/9781420013276.ch28 · Cited by 19
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Self-citationVillanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
Metadata
- Authors
- Papatheodoridis, G. V., Chan, H. L.-Y., Hansen, B. E., Janssen, H. L. A., & Lampertico, P.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 62
- Issue
- 4
- Pages
- 956-967
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2012824806
- Cited by
- 511
- References
- 48
- FWCI
- 34.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.